Companies in #Bispecifics
Found 1 company operating in this sector.
WuXi Biologics (HKEX: 2269) is a leading global Contract Development and Manufacturing Organization (CDMO) providing end-to-end biologics discovery, development, and manufacturing services — including monoclonal antibodies, bispecifics, antibody-drug conjugates, and recombinant proteins — from sites in China, Ireland, the U.S., and Singapore.